FDA Inspection 1021114 — Creative Testing Solutions

Creative Testing Solutions — FEI 1000140241

The FDA completed an inspection of Creative Testing Solutions on Jul 20, 2017 in Charlotte, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 20, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Charlotte, NC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.